US seeks information on potential misuse of F-16 by Pak

Agencies
March 2, 2019

Washington, Mar 2: The US is seeking more information on the potential misuse of American-made F-16 fighter jets by Pakistan against India in violation of the end-user agreement, the State Department has said.

The Indian Air Force on Thursday displayed parts of an AMRAAM beyond visual range air-to-air missile as evidence to "conclusively" prove that Pakistan deployed US-manufactured F-16 fighter jets during an aerial raid targeting Indian military installations in Kashmir after India's anti-terror operation in Balakot.

Pakistan on Wednesday categorically said that no F-16 fighter jets were used and denied that one of its planes had been downed by the Indian Air Force.

"We are aware of these reports and are seeking more information," a State Department spokesperson told PTI when asked about the report that Pakistan has violated end-user agreement with the United States in this week’s border clash with India.

"Due to non-disclosure agreements in Foreign Military Sales contracts, we cannot discuss the specifics of end user-agreements contained within," Lt Col Kone Faulkner, a Defense Department spokesperson told news agency.

The United States, which is the largest seller of high-tech defence equipment globally, and has a strong end-user monitoring agreement, as a matter of practice takes all allegations of misuse of defense articles very seriously.

But before making any judgement or arriving at any conclusion, it needs to establish some facts on the ground, if there has been any violation by Pakistan to the F-16 end-user agreement it signed by the United States.

According to Pentagon’s Defense Security and Cooperation Agency (DSCA) F-16 jets were meant to be used to "enhance Pakistan’s ability to conduct counter-insurgency and counterterrorism operations".

Publicly available documents reveal that US has imposed nearly a dozen restriction on Pakistan related to its use of F-16.

During a Congressional hearing on July 20, 2006, John Miller the then Assistant Secretary of State for Political-Military Affairs, had told lawmakers that the United States has "very carefully considered" the potential risks of the diversion of US technology and equipment."

While the exact details of the restrictions were discussed in a closed-door session and thus remains classified, Miller then broadly outlined some of the restrictions, which he said were over a "dozen new and unprecedented elements" of the security plan for Pakistan.

Miller then told lawmakers that the security provisions also include semi-annual inventories of all F-16 aircraft equipment and munitions, including related technical data, and more frequent inventories for other systems.

"There is a two-man rule, so to speak, for access to this equipment and restricted areas, and F-16 flights outside of Pakistan or participation in exercises and operations with third nations must be approved in advance by the United States government," the then top State Department official said, according to the transcripts of the hearing.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 12,2020

Beijing, Mar 12: The number of fresh infections at the epicentre of China's coronavirus epidemic dropped to a new low on Thursday but the country imported more cases from abroad.

Another 11 people died, the lowest daily increase since late January, bringing the toll in China to 3,169 deaths, according to the National Health Commission.

There were only eight new cases in Wuhan, the city where the virus first emerged in December before growing into a national crisis and a pandemic.

It is the first time that new cases in Wuhan, the capital of Hubei province, have fallen to single-digits since figures started to be reported in January.

With cases falling dramatically in recent weeks, authorities this week began to loosen some restrictions on Hubei's 56 million people, who have been under quarantine since late January.

Healthy people living in low-risk areas of the province can now travel within Hubei. While Wuhan is not included, some of the city's companies were told they could resume work.

Only one other non-imported case was recorded elsewhere in the country.

But as global hotspots emerge elsewhere, China fears that cases arriving from abroad could undermine its progress.

On Thursday there were six more imported cases reported, bringing the total of infections from overseas to 85, health officials said.

Beijing has ordered a 14-day quarantine for everyone arriving in the city from any country.

Travellers flying into Beijing Capital International Airport from high-risk countries are now handled separately from other passengers.

A total of 80,793 people have now been infected in China.

President Xi Jinping said this week during his first visit to Wuhan since the crisis erupted that the spread of the disease has been "basically curbed" in China.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 26,2020

Tokyo, Feb 26: Two more Indians onboard quarantined cruise ship -- Diamond Princess -- were tested positive for novel coronavirus, the Indian embassy here said on Tuesday, adding that those Indians not infected by the virus will be repatriated to the homeland on February 26.

A total of 16 Indian nationals onboard the luxury ship -- quarantined off the coast of Japan since February 5 -- have been tested positive for coronavirus so far, the embassy informed.

"A chartered flight is being arranged to repatriate Indian nationals onboard #DiamondPrincess, provided they have (a) consented; (b) not tested positive for #COVID19; (c) cleared by the medical team. An email advisory to this effect, with details, has been sent to them," the embassy tweeted.

The repatriation of the Indian nationals will be facilitated by the Indian government.

"PCR test results for ALL Indian nationals declared-02 more Indians tested positive to #COVID19, taking the total to 16. Those fulfilling conditions and consenting to repatriation to India on 26 Feb being facilitated by the Indian Government. Details shared with them," the following tweet read.

A total of 138 Indians, including 132 crew and 6 passengers, were among the 3,711 people on board the luxury cruise ship which was quarantine off Japan on February 5 after it emerged that a former passenger had tested positive for the virus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.